Vivid Seats Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
SEAT$1.49-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net income | $10,742 | $30,272 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 10,483 | 2,598 |
| Amortization of leases | 412 | 150 |
| Amortization of deferred financing costs | 236 | 226 |
| Equity-based compensation expense | 8,488 | 5,530 |
| Change in fair value of warrants | (460) | (327) |
| Change in fair value of derivative asset | 37 | — |
| Change in fair value of contingent consideration | — | 34 |
| Loss on asset disposals | 102 | 7 |
| Deferred taxes | 862 | — |
| Non-cash interest income | (142) | — |
| Foreign currency revaluation loss | 3,005 | — |
| Change in assets and liabilities: | ||
| Accounts receivable | (11,448) | (10,000) |
| Inventory | (8,491) | (11,370) |
| Prepaid expenses and other current assets | (2,778) | (3,417) |
| Accounts payable | 50,493 | 56,826 |
| Accrued expenses and other current liabilities | (20,379) | 444 |
| Deferred revenue | (1,691) | (6,063) |
| Other non-current assets and liabilities | (306) | 201 |
| Net cash provided by operating activities | 39,165 | 65,111 |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (92) | (215) |
| Purchases of personal seat licenses | (564) | (365) |
| Investments in developed technology | (4,631) | (2,027) |
| Net cash used in investing activities | (5,287) | (2,607) |
| Cash flows from financing activities | ||
| Payments of February 2022 First Lien Loan | (688) | (688) |
| Payments of Shoko Chukin Bank Loan | (281) | — |
| Repurchase of common stock | (3,105) | (7,612) |
| Payments for taxes related to net settlement of equity incentive awards | (462) | — |
| Payments of TRA liability | (77) | — |
| Cash paid for milestone payments | — | (2,500) |
| Net cash used in financing activities | (4,613) | (10,800) |
| Impact of foreign exchange on cash, cash equivalents, and restricted cash | (820) | — |
| Net increase in cash, cash equivalents, and restricted cash | 28,445 | 51,704 |
| Cash, cash equivalents, and restricted cash – beginning of period | 132,434 | 252,290 |
| Cash, cash equivalents, and restricted cash – end of period | $160,879 | $303,994 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $6,074 | $1,941 |
| Cash paid for income tax | $623 | $— |
| Cash paid for operating lease liabilities | $664 | $234 |
| Repurchase of common stock recorded in Accrued expenses and other current liabilities | $1,015 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.